Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Return on Sales (2019 - 2025)

Volitionrx filings provide 8 years of Return on Sales readings, the most recent being 0.69% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 55.0% to 0.69% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.04%, a 4.0% increase, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.69% in Q4 2025 for Volitionrx, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.05% in Q4 2021 to a low of 0.69% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.0% (2025), compared with a mean of 0.17%.
  • Biggest five-year swings in Return on Sales: surged 19078bps in 2021 and later tumbled -61bps in 2023.
  • Volitionrx's Return on Sales stood at 0.05% in 2021, then plummeted by -85bps to 0.01% in 2022, then crashed by -4654bps to 0.36% in 2023, then soared by 60bps to 0.14% in 2024, then crashed by -388bps to 0.69% in 2025.
  • The last three reported values for Return on Sales were 0.69% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.